Who is the CEO of Eight Sleep?

Matteo Franceschetti is the CEO of Eight Sleep. The company was founded in 2014.

Where is Eight Sleep located?

Eight Sleep is headquartered in New York, USA.

What funding stage is Eight Sleep at?

Eight Sleep is currently at the Established stage.

How many employees does Eight Sleep have?

Eight Sleep has approximately 150-200 employees.

Eight Sleep

Category: AI in Healthcare

An AI-powered sleep fitness platform that transforms the bed into an intelligent preventive health device, combining dynamic temperature regulation, biometric tracking, and predictive AI to optimize sleep quality and overall health. Eight Sleep was founded in 2014. The company is led by Matteo Franceschetti. Based in New York, USA. Team size: 150-200. Total funding raised: $316.0M. Latest round: Strategic Round ($50.0M, Mar 2026). Key investors include ["Tether Investments","HSG (HealthSpan Growth)","Valor Equity Partners","Khosla Ventures","Founders Fund","Y Combinator","SoftBank"].

Founded: 2014
Headquarters: New York, USA
Team size: 150-200
Total funding: $316.0M

Value proposition

Personalizes sleep through AI-driven temperature control (55°F-110°F), intelligent elevation adjustments, and real-time biometric monitoring to deliver clinically-proven improvements: up to 34% more deep sleep, 44% faster sleep onset, 45% snoring reduction, and 23% fewer night wakups, while proactively predicting health outcomes before sleep occurs.

Products and solutions

["Pod 5 Smart Mattress Cover (Core, Plus, Ultra, Ultra+ models)","Pod 4 Smart Mattress Cover","Pod Adjustable Base with elevation and snoring mitigation","Pod Blanket with hydro-powered thermal technology","Pod Pillow Cover with biometric sensors","Sleep Agent AI with digital twin predictive modeling","Autopilot AI algorithm for autonomous temperature optimization","Health Check anomaly detection feature","Mobile app with sleep analytics and insights"]

Unique value

Pioneered the 'sleep fitness' category as the first company to combine intelligent hardware, software, and AI for sleep optimization. Uses Sleep Agent AI to create thousands of digital twins of each user's sleep physiology, predicting outcomes and adjusting temperature, elevation, and routines before problems occur. Features seamless, non-invasive biometric sensors embedded in the bed surface for passive, clinical-grade health monitoring.

Target customer

Health-conscious consumers prioritizing wellness optimization, professional athletes requiring elite recovery, tech executives and biohackers, couples with differing temperature preferences, individuals with sleep challenges (insomnia, menopause symptoms, sleep apnea), and corporate wellness programs.

Industries served

["Sleep Technology & Smart Home","Healthcare AI & Preventive Medicine","Consumer Health & Wellness","Sports Performance & Athletic Recovery","Corporate Wellness Programs","Biohacking & Performance Optimization"]

Technology advantage

Proprietary Sleep Agent leverages large language models and advanced AI to interpret biometric data and simulate thousands of scenarios per user, enabling predictive sleep optimization rather than reactive adjustments. Combines dynamic temperature control (55°F-110°F with dual-zone personalization), intelligent elevation for snoring mitigation, embedded surround sound, and Autopilot algorithm that learns individual patterns over 7 days to autonomously optimize sleep. Over 1 billion hours of sleep data analyzed, supported by 50+ clinical studies.

How they differentiate

Only company combining AI-driven predictive health technology with dynamic temperature regulation, intelligent elevation, and biometric tracking through proprietary Sleep Agent AI that creates digital twins of users' sleep physiology. Features 49+ patents, 1B+ hours of sleep data analyzed, and 50+ clinical studies supporting efficacy claims.

Main competitors

["Sleep Number","ChiliSleep (Sleepme)","Orion"]

Key partnerships

["Mercedes-AMG Petronas Formula One Team (8X F1 Champions)","Charles Leclerc (Ferrari F1 Driver) - Athlete Ambassador & Investor","Taylor Fritz (ATP Tennis) - Athlete Ambassador & Investor","300+ Professional Athletes across F1, MLB, NFL, NBA, Tennis, Cycling, CrossFit","EF Pro Cycling Team (Tour de France)","Y Combinator (S15 Batch) - Strategic Partner & Investor","Strava - Integration Partnership","Corporate Wellness Programs (B2B Expansion)","Elite Performance Organizations and Teams"]

Notable customers

["Mercedes-AMG Petronas Formula One Team (8X F1 Champions)","Charles Leclerc (Ferrari F1 Driver)","Taylor Fritz (ATP Tennis)","Lewis Hamilton (F1 Champion)","Justin Medeiros (CrossFit Champion)","EF Pro Cycling Team (Tour de France)","300+ Professional Athletes across F1, MLB, NFL, NBA, Tennis, Cycling, CrossFit"]

Major milestones

["Y Combinator backing (S15 Batch, 2015)","Series B led by Khosla Ventures (Mar 2018)","Series C led by Valor Equity Partners at $500M valuation (Aug 2021)","Series D led by HSG at ~$1B valuation (Aug 2025)","Achieved free cash flow positivity (2025)","Surpassed $500M cumulative sales since 2019","Strategic round led by Tether Investments at $1.5B unicorn valuation (Mar 2026)","Launched Pod 5 with AI-driven predictive health features","Secured FDA pathway for sleep apnea diagnosis and mitigation","Analyzed over 1 billion hours of sleep data","Expanded to 30+ countries with China market entry underway"]

Growth metrics

Achieved free cash flow positivity in 2025. Surpassed $500M cumulative sales since 2019. Reached unicorn status with $1.5B valuation (Mar 2026). Products sold in 30+ countries with ongoing expansion.

Market positioning

Premium sleep fitness platform positioned at intersection of consumer wellness, sports performance, and healthcare AI. First-mover in 'sleep fitness' category with products used by 300+ professional athletes and major sports teams. Transitioning from consumer wellness to medical-grade predictive health technology with FDA pathway.

Geographic focus

North America (primary), Europe (UK, Belgium, France, Germany, Italy, Netherlands, Spain), Australia, Mexico, UAE. Currently expanding to China (400M middle-class target) and Singapore with Shenzhen manufacturing base providing cost efficiencies and regulatory familiarity.

Patents and IP

49+ patents filed worldwide covering thermoregulatory abilities, sensor technology, data analysis algorithms, and product designs. Key patents include US 10,792,461, US 11,666,284, US 11,904,103, US 12,274,564, US 12,370,339, US 12,377,240 for Pod technology; US 10,154,932, US 12,390,158 for Base; plus UK and international patents. Additional patents pending for AI-driven predictive health features.

About Matteo Franceschetti

Co-Founder and CEO of Eight Sleep (2014-present). Former Partner at Global Founders Capital (2013-2015), investing in early-stage technology companies. Previously practiced corporate law at top-tier international law firms (2009-2012). Co-founded GIR, acquired in 2014. Former competitive athlete with focus on performance optimization. Named to Forbes 30 Under 30 list for Consumer Technology. Y Combinator alumnus (S15 batch).

Official website: https://www.eightsleep.com/